SHC as reported
Sotera Health Company reported $1.22B of revenue over the trailing twelve months, +8.1% on the year before. 11 reported series are charted on this page, each one as filed.
$1.22B
Revenue, trailing twelve months · to Q2 2026 · +8.1% against the twelve months before
- Net Income
- $163M
Net Income · +581% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $113M
Free Cash Flow · +0.00% year on year · trailing twelve months to Q2 2026
- EPS
- $0.57
EPS · +533% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.22B | +8.1% | Q2 2026 |
| Net Income | $163M | +581% | Q2 2026 |
| EPS | $0.57 | +533% | Q2 2026 |
| Gross Margin | 55% | n/a | Q2 2026 |
| Op Margin | 27% | n/a | Q4 2024 · 6 quarters behind |
| Net Margin | 13% | n/a | Q2 2026 |
| ROE | 17% | n/a | Q2 2026 |
| ROA | 3.2% | n/a | Q2 2026 |
| ROIC | 10% | n/a | Q4 2024 · 6 quarters behind |
| Free Cash Flow | $113M | +0.00% | Q2 2026 |
| P/E | 34.3 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Sotera Health Company (SHC) - Revenue & ProfitRevenue & ProfitSotera Health Company (SHC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Diagnostics & Research
Ranks #18 of 29 by Smart Score